Co-Authors
This is a "connection" page, showing publications co-authored by Matthew Mefford and Jaejin An.
Connection Strength
1.416
-
Cost-effectiveness of implementing a home blood pressure telemonitoring program. Am J Manag Care. 2026 Mar; 32(3):146-152.
Score: 0.242
-
PREVENT Equation Performance in Asian and Native Hawaiian and Other Pacific Islander Groups. JAMA Netw Open. 2026 02 02; 9(2):e2556915.
Score: 0.240
-
Lipid-lowering Therapy Utilization, Adherence, and Outcomes Among Adults With and at-Risk for Atherosclerotic Cardiovascular Disease in an Integrated Healthcare Delivery System in Southern California. Am J Cardiol. 2025 Jul 13; 255:55-63.
Score: 0.231
-
Rates of Acute Myocardial Infarction During the COVID-19 Pandemic. Perm J. 2021 12 13; 25.
Score: 0.180
-
Risk of hospitalization and mortality associated with uncontrolled blood pressure in patients with hypertension and COVID-19. Int J Cardiol Cardiovasc Risk Prev. 2021 Dec; 11:200117.
Score: 0.179
-
COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system. Int J Cardiol Hypertens. 2021 Jun; 9:100088.
Score: 0.174
-
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
Score: 0.168